Page last updated: 2024-10-23

benzbromarone and Malignant Melanoma

benzbromarone has been researched along with Malignant Melanoma in 1 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Research Excerpts

ExcerptRelevanceReference
"Human malignant melanoma is characterised by unresponsiveness to conventional chemotherapy."1.30Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. ( Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, W1
Hauptmann, E1
Elbling, L1
Vetterlein, M1
Kokoschka, EM1
Micksche, M1

Other Studies

1 other study available for benzbromarone and Malignant Melanoma

ArticleYear
Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
    International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP-Binding Cass

1997